Literature DB >> 6322788

Insulin-like growth factor-I (IGF-I) stimulates tyrosine kinase activity in purified receptors from a rat liver cell line.

Y Zick, N Sasaki, R W Rees-Jones, G Grunberger, S P Nissley, M M Rechler.   

Abstract

Solubilized, lectin-purified receptor preparations from BRL 3A2 rat liver cells are rich in Type I and Type II IGF receptors, but possess few insulin receptors. High concentrations of IGF-I or insulin stimulate phosphorylation of a Mr congruent to 98K membrane protein in these preparations. Phosphorylation of a synthetic polymer of tyrosine and glutamic acid was stimulated by IGF-I greater than IGF-II congruent to insulin. These relative potencies, together with the results of immunodepletion experiments using an autoantibody to the insulin receptor, suggest that the effects of each of these hormones is mediated by the Type I IGF receptor. Our results are consistent with the Type I IGF receptor having intrinsic tyrosine kinase activity capable of phosphorylating the receptor itself and other substrates.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322788     DOI: 10.1016/0006-291x(84)91610-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Developmental regulation of the rat insulin-like growth factor I receptor gene.

Authors:  H Werner; M Woloschak; M Adamo; Z Shen-Orr; C T Roberts; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Association of p21ras with phosphatidylinositol 3-kinase.

Authors:  A Sjölander; K Yamamoto; B E Huber; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects.

Authors:  G R Freidenberg; R R Henry; H H Klein; D R Reichart; J M Olefsky
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

4.  Relationship of insulin binding and insulin-stimulated tyrosine kinase activity is altered in type II diabetes.

Authors:  R J Comi; G Grunberger; P Gorden
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

5.  Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver.

Authors:  J F Caro; J Poulos; O Ittoop; W J Pories; E G Flickinger; M K Sinha
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

6.  Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3.

Authors:  C R King; I Borrello; F Bellot; P Comoglio; J Schlessinger
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

7.  Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.

Authors:  A Ullrich; A Gray; A W Tam; T Yang-Feng; M Tsubokawa; C Collins; W Henzel; T Le Bon; S Kathuria; E Chen
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.